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642a Wednesday, February 19, 2014combined with functional modulation by membrane lipid and water-vestibules.
Here, we used electron paramagnetic resonance (EPR) spectroscopy to delin-
eate protein motions underlying GLIC gating in a membrane environment,
and report the interface conformation in the closed and the desensitized states.
Extensive intra-subunit interactions were observed in the closed state which are
weakened upon desensitization, and replaced by newer inter-subunit contacts.
Gating involves major rearrangements of the interfacial loops accompanied by
reorganization of the protein-lipid-water interface. These structural changes
may serve as targets for modulation of gating by lipids, alcohols and
amphipathic-drug molecules.
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The primary activation gate in voltage-gated Kv channels is formed by a helix
bundle crossing at the intracellular pore entrance. Among the evidence for this
model is that, in the presence of intracellular high-affinity quaternary ammo-
nium (QA) blockers, Kv channel activation is followed by a slow block that
is indicative of gated access of the blocker to a binding site inside the pore.
For several types of ligand-gated channels such as CNG and large-
conductance Ca2þ-activated Kþ (BK) channels, however, the channels’ selec-
tivity filter has been proposed to act as the conduction gate, in which case gated
blocker access is not expected. We investigated the location of the ligand-
controlled gate in the calcium-activated MthK channel, a prokaryotic BK chan-
nel homologue lacking voltage-sensor domains, using an assay for closed-state
channel block. In order to achieve fast MthK activation, we employed a Tlþ
flux assay using a stopped-flow spectrofluorometer. Purified MthK channels
were reconstituted into liposomes loaded with the fluorophore ANTS and chan-
nel activity was estimated from the rate of ANTS quenching due to Tlþ influx
through the channels. 10 mM Ca2þ resulted in an activation rate comparable to
the 2 ms mixing dead time. Using a sequential mixing protocol to apply the
high-affinity QA blockers tetrapentylammonium or bbTBA prior to channel
activation, we found that these molecules were able to fully block closed chan-
nels, indicating that the QA blockers can reach their binding site in closed chan-
nels. Given that the QA binding site is in the aqueous cavity below the
selectivity filter, these results suggest that there is a calcium-dependent gate
at the selectivity filter in MthK.
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C-type inactivation of voltage-gated ion channels commonly occurs from the
open state (open-sate inactivation, OSI) at strongly positive membrane poten-
tials or from pre-open closed states (closed-state inactivation, CSI) at modestly
depolarized membrane potentials. Slow recovery from inactivation requires hy-
perpolarized membrane potentials. C-type inactivation is known to result from
structural rearrangement or collapse at selectivity filter. BK channels are known
to be different from most voltage-gated Kþ channels due to the absence of a
classic intracellular cross-bundle activation gate, prompting suggestions of an
opening mechanism due to rearangements of the selectivity filter. We studied
C-inactivation in BK channels to explore the hypothesis that BK channel’s acti-
vation and C-inactivation may have closely related gating mechanisms. The BK
channel doesn’t have C-inactivation under physiological conditions because of
its high affinity to external Kþ. We observed prominent slow C-inactivation
and recovery upon providing two stimulating factors of C-inactivation: (1) mu-
tation Y294E/K/Q/S or Y279F, whose equivalent in Shaker channels(T449E/K/
D/Q/S or W434F) caused greatly increased rates of C-inactivation or constitu-
tive inactivation; (2) a very low concentration of extracellular Kþ by replace-
ment of Kþ with NMDGþ. However, BK channels showed a distinct state-
dependency of C-inactivation which occurs at negative membrane potentials
or decreased [Ca2þ]i that cause channels to close, whereas recovery from inac-
tivation requires positive membrane potentials or elevated [Ca2þ]i that promote
channel opening. Constitutively open mutatations prevented BK channel from
C-inactivation, suggesting the absence of an open- inactivated state. We con-
clud that channel closing is a prerequisite although not an equivalent to the
C-inactivation in the BK channels, indicating a strong coupling between thesetwo processes. Because C-inactivation can involve multiple conformational
changes at selectivity filter, the BK channel closing which can recover
(open) relatively quickly might represent an early conformational stage of C-
inactivation.
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Nicotinic acid adenine dinucleotide phosphate (NAADP) potently releases
Ca2þ from acidic intracellular lysosomal Ca2þ-stores. There is evidence that
two-pore channels (TPCs), a family of ion-channels localised to the acidic
stores, are involved in NAADP-mediated Ca2þ-release. We have shown that
human TPC type-2 (TPC2) possesses certain key biophysical properties that
suggest it may function as a lysosomal NAADP-sensitive Ca2þ-release channel
[1]. We now investigate whether two-pore channel type-1 (TPC1) exhibits
similar functional properties by reconstituting purified human TPC1 into artifi-
cial membranes under voltage-clamp conditions. Similar to TPC2, we find that
TPC1 is impermeable to Cl- but is poorly selective among cations with conduc-
tance decreasing in the order Kþ>Naþ>Ca2þ. We also find that, unlike TPC2,
TPC1 is highly permeable to protons; under bi-ionic conditions, relative perme-
ability decreases in the order Hþ>>Kþ>Naþ>Ca2þ. Significantly, we show
that the regulation of TPC1 gating is very different to that of TPC2. We previ-
ously demonstrated that TPC2 activity is not regulated by cytosolic Ca2þ [2]
but here find that TPC1 can be activated by nanomolar concentrations of
NAADP alone or by cytosolic Ca2þ alone. This fundamental difference in
channel regulation will enable TPC1 to be activated independently from
TPC2 allowing the endo-lysosomal system to respond to physiological needs
by integrating a variety of cellular signals. We suggest that in the endolysoso-
mal and lysosomal systems, TPC2 can effectively function as a NAADP-
activated Ca2þ-release channel. In contrast, TPC1 can leak protons from these
acidic Ca2þ-stores and although TPC1 is capable of providing some degree of
Ca2þ-release, this is heavily dependent on Kþ and Naþ gradients across the
lysosomal membrane, on the lysosomal membrane potential, the luminal
[Ca2þ] and the luminal pH.
[1].Pitt et al.,(2010)JBC;285:35039-46.
[2].Pitt et al.,(2011)Biophys.J;100:433a.
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Intermediate and small-conductance Ca2þ activated potassium (KCa) channels
play an important role in regulating membrane excitability and Ca2þ signaling.
Pharmacological activation of these voltage-independent channels has there-
fore been suggested for the treatment of various diseases. While KCa2 activa-
tors can reduce neuronal excitability in CNS disorders, KCa3.1 activators are
being discussed as endothelial targeted antihypertensives. KCa channels are
gated by Ca2þ binding to a constitutively associated calmodulin at the C-termi-
nus. Recent work (Zheng M. 2012 Nat Commun 3:1021) demonstrated that the
benzimidazolone 1-EBIO binds at the interface of the CAM N-lobe and the
calmodulin binding domain (CAMBD) of KCa2.2. Mutations of A477V/
L480M and A477I in KCa2.2 were shown to increase and decrease potency
of 1-EBIO, respectively. Here we report that the same mutations (A625V/
L628M and A625I) in KCa2.3 also alter the potency of KCa2/3 activators of
the benzothiazole class such as our recently developed SKA-31, a pharmaco-
logical tool compound that has been widely used to study the role of KCa2
and KCa3.1 channels. However, like 1-EBIO and NS309, SKA-31 suffers
from a lack of selectivity between KCa3.1 and KCa2 channels making it diffi-
cult to interpret in vivo observations made with this compound. Via a structure
activity relationship (SAR) study we have optimized the pharmacophore of
SKA-31 and have now identified SKA-111 (5-methylnaphtho[1,2-d]thiazol-
2-amine), which displays 160-fold selectivity for KCa3.1 (EC50 = 118 5 29
nM) over KCa2.3 (EC50 = 11.25 4 mM). SKA-111 constitutes a novel phar-
macological tool to study the role of KCa3.1 in blood pressure regulation. SKA-
111 selectively potentiates native KCa3.1 currents in porcine carotid endothe-
lium and lowers blood pressure in mice. SKA-111 should further be useful to
help understand what structural elements confer selectivity between KCa3.1
and KCa2 activation to the benzothiazole pharmacophore.
